Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Clovis Oncology, Inc. | Officer | Common Stock | 114K | $112K | $0.98 | Nov 2, 2022 | Direct |
CERO THERAPEUTICS HOLDINGS, INC. | Director | Stock Option (Right to Buy) | 113K | Mar 25, 2024 | Direct | ||
Clovis Oncology, Inc. | Officer | Restricted Stock Units | 23.1K | Nov 1, 2022 | Direct | ||
Atreca, Inc. | Director | Stock Option (right to buy) | 12K | Jun 13, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CERO | CERO THERAPEUTICS HOLDINGS, INC. | Mar 25, 2024 | 1 | $0 | 4 | Mar 27, 2024 | Director |
CERO | PHOENIX BIOTECH ACQUISITION CORP. | Feb 14, 2024 | 0 | $0 | 3 | Feb 16, 2024 | Director |
BCEL | Atreca, Inc. | Jun 13, 2023 | 1 | $0 | 4 | Jun 15, 2023 | Director |
CLVS | Clovis Oncology, Inc. | Nov 1, 2022 | 6 | -$4.19K | 4 | Nov 3, 2022 | Officer |
CLVS | Clovis Oncology, Inc. | Sep 1, 2022 | 3 | -$3.05K | 4 | Sep 6, 2022 | Officer |
CLVS | Clovis Oncology, Inc. | Aug 1, 2022 | 6 | -$6.33K | 4 | Aug 3, 2022 | Officer |
BCEL | Atreca, Inc. | Jun 8, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
CLVS | Clovis Oncology, Inc. | Jun 1, 2022 | 3 | -$1.7K | 4 | Jun 3, 2022 | Officer |
CLVS | Clovis Oncology, Inc. | May 1, 2022 | 6 | -$8.38K | 4 | May 3, 2022 | Officer |
CLVS | Clovis Oncology, Inc. | Mar 1, 2022 | 7 | -$20.4K | 4 | Mar 3, 2022 | Officer |
CLVS | Clovis Oncology, Inc. | Feb 1, 2022 | 6 | -$8.76K | 4 | Feb 3, 2022 | Officer |
CLVS | Clovis Oncology, Inc. | Dec 1, 2021 | 3 | -$1.04K | 4 | Dec 3, 2021 | Officer |
CLVS | Clovis Oncology, Inc. | Nov 1, 2021 | 6 | -$19.2K | 4 | Nov 3, 2021 | Officer |
CLVS | Clovis Oncology, Inc. | Sep 1, 2021 | 3 | -$1.7K | 4 | Sep 3, 2021 | Officer |
CLVS | Clovis Oncology, Inc. | Aug 1, 2021 | 6 | -$20.2K | 4 | Aug 3, 2021 | Officer |
BCEL | Atreca, Inc. | Jun 9, 2021 | 1 | $0 | 4 | Jun 11, 2021 | Director |
CLVS | Clovis Oncology, Inc. | Jun 1, 2021 | 3 | -$1.81K | 4 | Jun 3, 2021 | Officer |